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An expression vector has been constructed which increases the expression of serine acetyltransferase (SAT) from E. coli to 17% of the soluble cell 
protein. A novel purification procedure, using dye-affinity chromatography, allows purification of SAT to homogeneity. The enzyme has been crys- 
tallised from polyethylene glycol, in the presence of L-cysdne (an inhibitor of SAT). The crystals which diffract to beyond 3.0 A resolution are 
of the tetragonal spacegroup P4,2,2 (or P4,2,2) with cell dimensions a=6= 123 A, c= 79 A. Since ultracentrifugation and gel-filtration experiments 
indicate that purified SAT is a tetramer, there appears to be one-half tetramer in the asymmetric unit (V,,, = 2.55 &/Da). 
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1. INTRODUCTION 
Serine can be converted to cysteine by a wide variety 
of organisms including bacteria [1,2], fungi [3], and 
higher plants 141. The pathway comprises two steps: 
L-serine + acetyl-coenzyme A --t 0-acetyl-L-serine f 
coenzyme A (1) 
0-acetyl-L-serine + sulphide-tl-cysteine + acetate (2) 
Step 1 is catalysed by serine acetyltransferase (SAT; EC 
2.3.1.30) while step 2 is catalysed by 0-acetyl-L-serine 
(thiol) lyase (EC 4.2.99.8). The SAT gene has been clon- 
ed from E. coli [S] and expressed at 0.2% soluble cell 
protein. Purification protocols have also been described 
previously [ 1,2,5]. 
tion to be competitive with respect to coenzyme A, a 
somewhat surprising finding given the lack of structural 
similarity between the two compounds. The inhibition 
constant Ki, is very low (1 pM), whereas the K, for 
serine is three orders of magnitude weaker (1 mM). 
Nonetheless, in the absence of cysteine, no significant 
inhibition of the enzyme is apparent until a serine con- 
centration of 5 mM. Thus the enzyme is able to 
distinguish between two remarkably similar compounds 
with a very high degree of specificity. In order to in- 
vestigate the structural basis for this specificity, SAT 
has been over-expressed, purified, and crystallised as a 
prelude to studies by X-ray diffraction. 
2. EXPERIMENTAL 
2.1. Enzyme assays 
Serine acetyltransferase shows a number of in- 
teresting enzymological properties. Firstly, the enzyme 
probabiy functions in vivo as a tightly bound complex 
with 0-acetyl-L-serine (thiol) lyase, since the two en- 
zymes copurify even after a number of diverse purifica- 
tion procedures (e.g. salt precipitation, ion-exchange, 
gel filtration) [l]. The bifunctional complex has been 
referred to as ‘cysteine synthase’ [2]. The stability of 
this complex, in both ~~~~o~e~~a typ~i~ffriu~ and E, 
coli, is reduced by the presence of 0-acetyl-L-serine - 
the product of the SAT cataiysed reaction. 
These were performed according to [l] by monitoring the increase 
in absorbance at 412 nm due to the reaction of the CoA thiolate anion 
with 5,5-dithiobis(2-nitrobenzoate) (DTNB). For assays in the 
presence of cysteine (which reacts with the DTNB), the cleavage of the 
thioester bond of acetyI-coenzyme A was monitored directly by the 
absorbance change at 232 nm [ 11. 
2.2. Recombinant DNA techniques 
Serine acetyltransferase is inhibited by cysteine [l]. 
Steady-state kinetic measurements uggest he inhibi- 
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Plasmid pWT2 was kindly provided by Prof. A. Bock, Munich 
University. Unless otherwise stated, all in vitro DNA manipulations 
were carried out according to [6]. A 3.7 kb BamHI fragment was ex- 
cised from pWT2 and inserted into the BamHI site of pUC19 [7] to 
give pSAT1 (Fig. I). A 800 bp Sau%I fragment was removed from 
pSATI and purified by extraction from low melting point agarose. 
The 5’ overhangs were removed by digestion with mung bean 
nuclease (New England Biolabs) in accordance with the supplier’s in- 
structions. After the blunt-ended fragment had been further digested 
with ClaI, the resulting 550 bp and 250 bp fragments were separated 
by agarose gel etectrophoresis. In a separate incubation, pSAT1 was 
digested with C/a1 and PSI, to excise a 1.5 kb CtuI/PstI fragment. In 
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Barn HI Sau 96 I 
(2.7kb) 
7 f3a 
Barn HI Sal I 
i) Mung bean nuclease 
ii)Cla I 
(0.55kb) 
TmGTAAGCA ATG TCG... 
Met Ser 
TCjz&TA AGC A ATG TCG . . 
Met Ser 
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a tripartite ligation, the 550 bp (5’-blunt/CluI) and 1.5 kb ClaI/PstI 
fragments were ligated into the plasmid pKK223-3 (Pharmacia), be- 
tween the &al and Psfl sites, to give pSAT2. 
Plasmid pSAT3 was prepared by site-specific mutagenesis accor- 
ding to [8] using the 550 bp EcoRI/Clal fragment from pSAT2. The 
mutated DNA fragment was sequenced and then used to replace the 
equivalent fragment in pSAT2 to give pSAT3. 
2.3, Preparation of Cibacron-bhte Sepharose 
This was prepared by mixing 5 g of Cibacron-Blue F3GA (Sigma) 
wirh 100 ml of Sepharose 6B (Pharmacia) in 100 ml of sodium car- 
bonate buffer at pH 9.5. The gel was incubated overnight at 60°C, 
and then washed in 6 M urea, 2 M sodium chloride until dye could no 
longer be washed from the gel. The Cibacron-blue gel was then 
equilibrated in 20 mM Tris-HCI (pH 7.5), and stored in the same buf- 
fer (containing 0.01% sodium azide) at 4°C. 
2.4. Protein purification 
Because of the moderate cold lability of this enzyme [I], ail pro- 
cedures were performed at room temperature unless otherwise stated. 
Protein was prepared from cultures of E. coli (JM lOl), harbouring 
pSAT3. Cultures (typically 2 x 500 ml) were grown in 2YT broth [6] 
at 37°C with agitation. Ampicillin was added to a concentration of 
100 pg/mf. In addition, 1 mM L-cysteine and 10 mM L-serine were 
added to assist cell growth (see below). Cultures were grown until 
Asoo=0.5, and then induced by the addition of isopropyl- 
thiogalactoside to 1 mM. A further addition of L-cysteine and L- 
serine (I and 10 mM, respectively) was made at this stage. Cells were 
harvested by centrifugation, and resuspended in 20 mM Tris HCI 
(pH 7..5), I mM EDTA, 1 mM dithiothreitol. The cells were disrupted 
by sonication and a cell-free extract was prepared by centrifugation 
(10 000 x g) at 4°C. This cell extract was heated to 60°C in a water- 
bath set at ?O”C, and then maintained at 60°C for 5 min. The solution 
was cooled on ice for 5 mm and then centrifuged to remove the 
precipitated protein. Ammonium sulphate (0.35 g/ml extract) was 
added to the supernatant to precipitate a protein fraction which in- 
cluded SAT. The precipitate was collected by centrifugation, and 
resuspended in at least 100 ml of 20 mM Tris-HCI (pH 7.5). This sam- 
pie was then applied to a 40 ml Cibacron-blue Sepharose column at 
a flow rate of 50 ml/h, and washed exhaustively with 0.i M NaCI, 20 
mM Tris-HCl (pH 7.5). The SAT was eluted with 20 mM Tris-HCI 
(pH 7.5) containing 100 aM L-cysteine. Only fractions with an AZSO 
greater than 0.15 were pooled. The eluted protein was concentrated to 
10 mg/ml by ultrafiltration, and then stored at room temperature 
after the addition of Tris-WC1 (pH 7.5) to a final concentration of 100 
mM. 
2.5. Molecular mass determinations 
Ultracentrifugation experiments were performed at 25°C using pro- 
tein at a concentration of 0.5 mg/ml in 100 mM Tris-HCI (pH 7.5) 
containing 100 pM L-cysteine. 
Gel filtration experiments were carried out using an FPLC system 
(Pharmacia) at 25°C. Protein (0.5 ml at 0.2 mglml) was passed 
through a Superose 6 and Superose 12 HR 10130 column in series, at 
a flow rate of 0.4 mlimin. Elution volumes were calibrated using a 
number of molecular weight standards (see Fig. 2). Experiments were 
performed in 0.15 M KCl, 50 mM potassium phosphate (pH 7.5) in 
the presence and absence of IO0 pM L-cysteine. 
2.5. Cr~s~~~~isation 
Crystals were prepared by vapour diffusion [9], in hanging drops, 
from polyethylene glycol (PEG) 1000. Equal volumes of protein solu- 
tion (at 10 mg/ml) and reservoir solution were mixed and left to 
equilibrate for 2-4 weeks at room temperature. After this time 
crystals were observed in drops over wells containing 8-16% PEG 
1000, 10 mM Tris . HCI (pH 7.5). 
3. RESULTS AND DISCUSSION 
3.1. Over-expression 
Previous studies (51 demonstrated that clones con- 
taining the plasmid pWT2 express SAT at around 0.2% 
of the soluble cell protein when grown in minimal 
medium to an A4z0 of 1.0. Although some 40-fold 
higher than expression from the chromosomal gene, the 
low cell density requires that large volumes of culture be 
grown in order to prepare sufficient quantities of SAT 
for structura1 studies. In order to improve the level of 
expression of SAT, a 3.7 kb BarnHI fragment was sub- 
cloned from pUCl9 to give plasmid pSAT1. Strains of 
E. coli containing these plasrnids have approximately 
lo-fold increased copy number over pWT2 (data not 
shown) and show an increased level of expression of 
SAT, by a factor equivalent to the increase in copy 
number. NonetheIess, such host/vector systems tilf on- 
ly yield 2-3 mg SAT/litre of cell culture. The sub- 
cloning of the SAT gene into pKK223-3, which carries 
the powerful IPTG-inducible TAC promoter [lo], both 
increases expression levels and has the advantage of 
providing some control over expression. Hence, clones 
carrying pSAT2 not only expressed SAT at 5 mgllitre of 
culture wtihout induction, but were capable of 10 
rng/litre when induced by the addition of IPTG. The 
poor agreement between the ribosome binding site Cjust 
5 ’ of the SAT gene in pSAT2) and that of the consensus 
sequence from other highly expressed genes in E. cofi 
[l I] was identified as the limitation to the levet of ex- 
pression of the gene. Consequently, site-specific 
mutagenesis was used to alter the ribosome binding site 
to one which more closely matched the consensus e- 
quence. The resultant plasmid (pSAT3) showed increas- 
ed expression levels of SAT to 30 mg/litre after induc- 
tion, but this increased level of expression appeared to 
be harmful since cultures failed to reach high densities. 
A possible explanation is that the over-expression of 
SAT results in a reduced intracellular concentration of 
serine (because it becomes acetylated) which then im- 
pairs the rate of protein synthesis. In order to overcome 
this problem, 1 mM cysteine and 10 mM serine were 
added to the culture medium to inhibit SAT and to en- 
sure the availability of serine. The addition of either 
serine or cysteine alone was not sufficient to sustain 
growth to high cell density. Cultures grown in the 
presence of additional cysteine and serine did grow to 
high cell density and produced SAT at a ievei of around 
100 mg/litre. 
Fig. 1, Preparation of pSAT3. Hatched regions indicate DNA coding for proteins (bra = &lactamase; sat = serine acetyltransferase; /ac = DNA 
derived from the lactose operon). Open boxes indicate ribosome binding sites, while filled boxes indicate promoter sequences. The modification 
of the Shine Daigarno sequence at the 5’ end of the sat gene in pSAT2 which was made to prepare pSAT3 is indicated. 
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Sample Volume 
(ml) 
Table 1 
Purification of SAT 
Protein Activity 
(mg) &mol/min) 
Specific activity 
(pmol/min/mg) 
Yield 
(%) 
Cell extract 60 735 8820 12.0 100 
Heat extract 58 319 6950 21.8 19 
(NH&S04 160 232 5660 24.4 64 
SAT pool 41 58 4150 71.6 47 
3.2. Purification of SAT 
Procedures for the purification of SAT which have 
been described previously [1,2,5] involve a large 
number of steps and are consequently very time con- 
suming, and the reported yields are rather low 
(0.2-9%). We present here an alternative method of 
purification which enables rapid purification of SAT in 
high yield, and with a high specific activity (Table I). 
It is known that a number of proteins which bind 
compounds containing an AMP moiety will bind the 
dye Cibacron-blue. SAT was found to bind very tightly 
to Cibacron-blue Sepharose, but can be eluted in a 
number of different ways. When the bound protein was 
eluted from the column with a salt gradient, the SAT 
was eluted in a broad peak with a consequent dilution 
of the protein. In addition the eluted protein, although 
purified considerably over the starting material, was 
observed to be rather impure by SDS polyacrylamide 
gel elctrophoresis. Elution from the column with a salt 
step directly, eluted the SAT in a sharper peak but at an 
even lower purity (data not shown). Since L-cysteine 
6 I 
10 
r 
5 h 
I I I I n L I 1 
28 30 32 34 36 30 40 42 
Elution Volume (ml) 
Fig. 2. FPLC gel-filtration of SAT. Standards used were im- 
munoglobulin G (160 000 Da), bovine serum albumin (66 000 Da), /3- 
lactoglobulin (35 000 Da), cytochrome c (12 000 Da) and vitamin BIZ 
(1400 Da). The elution point of SAT (in both the presence and 
absence of cysteine) is indicated by the arrow. 
shows competitive inhibition kinetics, with respect to 
acetyl-coenzyme A [l], it seemed an attractive strategy 
to use the inhibitor to elute the bound SAT from the 
dye-column. Although SAT purified in this way still 
eluted in a rather broad peak (typically greater than one 
column volume), protein was very pure. The specific ac- 
tivity of the eluted protein was 70-80 U/mg - some 
2-3-fold higher than that prepared by other methods 
[ 1,2,5] possibly because of the speed of the purification 
procedure (typically 6 h from cells to pure protein). 
The kinetic properties of SAT prepared by this 
method were the same as those described for SAT 
purified by other methods [ 1,2,5]. 
3.3. Oligomeric structure of purified SA T 
Ultracentrifugation and gel-filtration experiments 
were carried out to determine the quaternary structure 
of purified SAT from estimates of the native molecular 
mass of the protein. Ultracentrifugation experiments in 
the presence of 100 PM L-cysteine indicated a molecular 
mass of 125 000 Da. This result was in reasonable 
agreement with the gel-filtration experiments, which 
suggested a molecular mass of 160 000 Da. The 
molecular mass appeared to be independent of the 
presence or absence of cysteine (Fig. 2). From these 
results, taken in conjunction with the crystallographic 
data presented below, we deduce that purified SAT 
(subunit M, = 29 261) is a tetramer. 
3.4. Crystallography 
Crystals were obtained after 2-4 weeks at room 
temperature, and are shown in Fig. 3. Typically these 
reached a maximum size of 0.25 x 0.15 mm. X-Ray 
analysis of these crystals showed diffraction to beyond 
3.0 A resolution using Synchrotron radiation 
(Daresbury, UK), but showed signs of disorder at high 
resolution. When viewed down the long axis of the 
crystal, the diffraction exhibited 4-fold symmetry with 
a primitive lattice. Systematic absences in this zone and 
others identified the spacegroup as P4r2r2 or P432i2 
with a = b = 123 A and c= 79 A. The number of SAT 
subunits in the asymmetric unit can be estimated accor- 
ding to [ 121. With one subunit, V,,, would be im- 
plausibly high at 5.1 A3/Da, while with three subunits, 
I/m would be rather low at 1.7 A3/Da. Hence the most 
likely situation is one in which there is one-half SAT 
tetramer in the asymmetric unit resulting in a I’,,, of 
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Fig. 3. Crystals of SAT grown from polyethylene glycol. The largest crystals grew to a size of 0.25 x 0.15 x 0.15 mm. 
2.55 A3/Da. Because part of the molecular symmetry of 
the SAT tetramer is expressed crystallographically, the 
tetramer must sit on a crystallographic two-fold axis. 
The positjons of the other two-fold axes of the tetramer 
should be readily determined using the rotation func- 
tion [13], and will aid the interpretation of derivative 
Patterson maps. 
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